Eyeing Neurology Drug Development: 2H Trial Readouts to Watch for in 2025
Neurology experts anticipate groundbreaking clinical trial results in 2025, potentially transforming treatment strategies for various neurological conditions.
As 2025 moves into its second half, the neurology community is looking ahead to another wave of pivotal clinical trial readouts that could reshape the landscape of care. These upcoming results span a broad spectrum of neurological conditions and represent critical steps in the development of both established and emerging therapies. From novel neuromodulation devices to first-in-class small molecules and cell-based interventions, the data expected in the coming months may refine diagnostic strategies, guide treatment decisions, and expand therapeutic possibilities. In this feature, NeurologyLive® highlights the trials to watch, detailing their design, objectives, and the potential impact of their findings on the future of neurologic care.